ReShape Lifesciences, Inc.

Q4 2022 13F Holders

Symbol
RSLS
CUSIP
76090R200
Type
Equity
Class
COM
Num filings
11
Total reported value, excl. options
$12.2 k
Manager Report Date Value ($000) Shares Option Type